President Donald Trump on Thursday will soon land in the United Arab Emirates for his final stop in the Middle East this week in a visit that marked the first time a U.S. president has traveled to the nation in nearly 30 years, following President George W. Bush's trip in 2008.Trump, who has secured major business deals first in Saudi Arabia and then Qatar, is expected to announce more agreements with what has long been one of the U.S. chief trading partners in the region though given recently announced trillion-dollar deals, it is unclear what more the Emiratis will agree to.In March, the UAE pledged a $1.4 trillion investment in the U.S. economy over the next decade through AI infrastructure, semiconductor, energy and American manufacturing initiatives, including a plan to nearly double U.S. aluminum production by investing in a new smelter for the first time in 35 years.TRUMP SIGNS AGREEMENTS WITH QATAR ON DEFENSE AND BOEING PURCHASESOn the eve of the presidents visit to the Middle Eastern nation, the State Department also announced a $1.4 billion sale of CH-47 F Chinookhelicopters and F-16 fighter jet parts to Abu Dhabi.However, lawmakers on Wednesday suggested they may block this sale amid concerns over direct personal business ties, as Trumps crypto venture has also received a $2 billion investment by a UAE-backed investment firm."If I was a betting person, Id bet that the Emiratis almost certainly kept some things in reserve for President Trumps actual visit that can be announced when hes on the ground in Abu Dhabi," John Hannah, former national security advisor to Dick Cheney and current Randi & Charles Wax senior fellow at the Jewish Institute for National Security of America (JINSA), told Fox News Digital. "I wouldnt be at all surprised if we see some new items unveiled or some additional details put out on some of the earlier announcements.""The UAE has clearly staked its future on being the Middle East leader in a wide range of 21st-century technologies, from AI to chips to space," he added. "And of course, the shopping list for high-end weapons is almost limitless and always a possible deliverable for a trip like this." Increased scrutiny arose around Trumps Middle East tour as engagement with all three nations holds personal value to him, given the Trump Organizations luxury resorts, hotels, golf courses, real estate projects and crypto investment schemes in the region.TRUMP CONTINUES TO DEFEND QATAR GIFTING US $400M JET: 'WE SHOULD HAVE THE MOST IMPRESSIVE PLANE'But all three nations also hold significant value to Washington, as they have become key players in some of the toughest geopolitical issues facing the U.S. and its allies.Saudi Arabia and Qatar have been integral in facilitating U.S. negotiations when it comes to ending Russias war in Ukraine and hostage negotiations in the Gaza Strip.While neither of these issues appeared to be top points of discussion in Trumps visit to Saudi Arabia or Qatar, he may hit on geopolitical ties more heavily when it comes to the UAE, particularly given that Abu Dhabi is one of the few Middle Eastern nations that holds normalized diplomatic ties with Israel.The UAE has ardently opposed Israels military operations in the Gaza Strip, has called for a two-state solution, and has rejected Trumps "riviera plans," instead favoring an Egypt-reconstruction alternative.But Abu Dhabi has also maintained relations with the U.S. biggest adversaries, including China, Russia and Iran, which could be a topic of conversation during Trumps one-day visit."As everywhere on this trip, the headlines will likely be dominated by the dollar signs and deal-making," Hannah said. "But Im personally most interested in the geopolitical angle of trying to reset the U.S.-Emirati strategic partnership, especially in the context of Americas great power competition with China and to a lesser extent Russia, and regionally with Iran."Hannah explained that Trump's visit to the UAE exemplifies a recommitment by the U.S. economically and militarily to support Abu Dhabis "stability, security, and success in a dangerous neighborhood" and could "pay real dividends going forward.""The UAEs top leadership has come to believe that putting most of its eggs into the American basket was an increasingly risky bet as one president after another decided that the Middle East was a lost cause nothing but blood and sand as President Trump famously said in his first term and the country needed to pivot its focus toward Asia," he continued. "With a country as influential and resource-rich as the UAE, correcting that unhelpful perception and putting the strategic relationship back on a much more positive dynamic is an important goal."

On May 5, President Donald Trump signed anexecutive orderoutlawing future federal funds going to gain-of-function research. This move comes as the nation begins to reckon with the broader failures of its pandemic response failures that extended far beyond the lab and into every aspect of public health policy.As the acute phase of the COVID-19 pandemic fades into the rearview mirror, the United States finds itself engaged in postmortems: on lockdowns, vaccines, school closures and public trust. But theres one glaring lesson the U.S. has yet to fully absorb its health strategy during crises cant rely on just one type of tool. A narrow, binary response to COVID-19 cost lives. The country must do better next time.During the pandemic, the public was often presented with asimple directive: get vaccinated or take your chances. While most Americans indeed should have gotten vaccinated, policymakers should have provided more room for nuance and variation. They ignored a core truth of medicine no single solution fits every individual. The virus evolved. Patient responses varied. But the official toolkit did not adapt.What the U.S. needed (and still needs) is a robust, flexible public health approach that supports a range of modalities: vaccines, yes, but also antivirals, monoclonal antibodies (mAbs) and emerging biologics.TRUMPS HEALTHCARE ORDER WILL HELP FIX HEALTHCARE FOR EVERYONEA resilient system is one that can pivot quickly, match patients with the right intervention and adapt as science advances.Monoclonal antibodies offer a clear example of what went wrong. These therapies,provento reduce hospitalizations and deaths among high-risk patients, were widely distributed early in the pandemic and used successfully by top federal officials,includingthe president. But in late 2021 and early 2022, federal authorities stopped distributing them,citingreduced efficacy against new variants.This was a mistake. mAbs are aplatform technology. They can be tailored to variants and deployed quickly. They are especially important for those who dont respond well to vaccines. But nearly five years after the start of the pandemic, no mAb has received full FDA approval for respiratory virus prevention despite meeting the same safety and efficacy benchmarks used to fast-track other medical countermeasures.Meanwhile, the public was encouraged to rely on booster shots which, while still additive, lost efficacy as the pandemic continued. CDC data show that the bivalent booster provided only37%protection against hospitalization for adults over 65 after several months. For the immunocompromised, protection was even lower. Yet, therapies that could have closed that gap were taken off the table.TRUMP IS RIGHT TO BLOCK 'DANGEROUS' GAIN-OF-FUNCTION RESEARCHThe U.S. should have maintained an all-of-the-above approach to treatment so its health professionals could make patient recommendations on a case-by-case basis, ensuring the most vulnerable Americans receive adequate protection.More broadly, five years later, the U.S. still lacks a proactive framework for deploying flexible, evidence-driven therapeutics in a public health emergency. The U.S. needs a system that doesnt just rely on whatever is first to market; it needs one that actively supports a diversified portfolio of tools.That means empowering agencies like the Biomedical Advanced Research and Development Authority and the National Institutes of Health to invest in adaptable countermeasures antibody platforms, broad-spectrum antivirals, rapid diagnostics and therapeutic RNA technologies. It also means modernizing the FDAs approval pathways to reflect the pace of innovation. When real-world evidence shows that a therapy is saving lives, regulators should have the flexibility to act.Congress can help by authorizing funding streams that reward versatility, creating incentives for companies to maintain and adapt an all-of-the-above treatment approach, and ensuring public-private partnerships are built for speed and scale. Legislation could also establish a standing procurement mechanism for variant-specific updates, not just vaccines.CLICK HERE FOR MORE FOX NEWS OPINIONAll of this will help to mitigate the damage of one of the greatest casualties of the pandemic the decline of public trust in Americas health institutions. This erosion stemmed from the sense that key decisions lacked transparency or failed to account for patients diverse needs.According to a2022 Pew Research Center survey, only 29% of U.S. adults said they had a great deal of confidence in medical scientists, down from 40% at the beginning of the pandemic. Trust in public health officials followed a similar decline.A more transparent, inclusive approach, where policymakers communicate the rationale behind treatment shifts and openly assess real-world outcomes, can help rebuild that trust. A better system would emphasize data-sharing, clear communication, and respect for physician judgment in tailoring care to patient needs.COVID-19 exposed the limits of the U.S. current playbook. A more effective future demands flexibility, pluralism and the humility to admit health policymakers dont always know right away what will work best, or for whom.But if regulators build the right system one that encourages innovation, evaluates outcomes in real time, and keeps every safe and effective tool on the table they wont have to learn this lesson again the hard way.CLICK HERE TO READ MORE FROM DR. TOM PRICE

You could be arrested, detained, and deported by the Trump administration.Yes, you, reading this."But," you might say, "Im a U.S. citizen. My parents were, too. I havent done anything wrong."It may not matter. As this administration ramps up mass deportations, you too could be detained and deported purely by mistake. All because you never got a fair day in court.TRUMP'S REMARKS COULD COME BACK TO BITE HIM IN ABREGO GARCIA DEPORTATION BATTLEWe all know the administration is making mistakes. After all, theyve told us.Youve probably heard of Kilmar Abrego Garcia the Maryland resident deported to El Salvador earlier this year. The administrations own lawyers said removing him from the country was "an administrative error."Hes certainly not the only mistake. The Trump administration is reportedly paying millions to the El Salvadoran government to keep him and 287 other men imprisoned. The administration says theyre violent gang members, but most of them have no criminal record in the United States or in any other country. The evidence the government says it relied on? They have tattoos of their favorite soccer team, or a Chicago Bulls hat.This administration has even mistakenly detained U.S. citizens. 19-year-old Jose Hermosillo was arrested by Border Patrol on the street in Tucson. According to his attorneys, he told the officers he was a U.S. citizen. They didnt believe him. Jose was held for 10 days before his family was able to show an immigration judge his birth certificate. Julio Noriega was detained by ICE in Chicago even though he had proof of his U.S. citizenship in his wallet. Bachir Atallah, a U.S. citizen who voted for Trump in November, was detained along with his wife on suspicion of being undocumented immigrants as they were returning from a family vacation. At least three U.S. citizen children have been detained and removed from the country without a hearing.Unfortunately, these mistakes are likely to become more frequent as mass deportations ramp up. According to the administration, reaching President Trumps stated goal of 1 million deportations a year will require them to more than double their current pace. More haste and a higher frequency means more mistakes.Expecting our entire government to be perfect is a fools errand, regardless of which party is in charge. Of course, mistakes happen. Thats why our Framers wrote due process safeguards into the Constitution. The Fifth Amendment says that "no person" shall be "deprived of life, liberty, or property, without due process of law."Justice Antonin Scalia, a constitutional conservative, wrote: "it is well established that the Fifth Amendment entitles aliens to due process of law in deportation proceedings." In April, the Supreme Court unanimously said that migrants are entitled to an opportunity to challenge their removal before they are sent out of our country.Despite that clear directive, the administration is trying to end these longstanding protections. President Trump has asked, "How can you give due process to people who came into our country illegally?"We know the answer. Tell would-be deportees the charges against them. Allow them to talk to their lawyer and explain to a judge why they shouldnt be deported. Have the government present its evidence, and let the accused present their own. These hearings are much shorter than a criminal trial, but theyre essential to give our citizens a fair chance to stop their mistaken deportation. Its what saved Jose Hermosillo, who was released after showing his proof of citizenship to a judge.The Trump administration is taking away that protection in many cases no access to lawyers, not even the briefest of hearings before an immigration judge. Theyre sending migrants to prisons overseas and then saying they have no control over them there. If someone is imprisoned in the United States and evidence that clears them comes to light, their sentence can be overturned. Yet, the administration is saying that once someone is sent to a prison in El Salvador, "the only way out is in a coffin," as the countrys Justice Minister has put it. And now Stephen Miller, the Presidents deputy chief of staff senior for policy, says theyre considering suspending habeas corpus, the important protection in our Constitution that ensures anyone can challenge their detention before a judge. Stripping away this central due process right would be a dramatic and dangerous escalation in Trumps efforts to prevent judges from ensuring our rights are protected.I agree that our broken immigration system moves too slowly. Last year, I supported legislation to invest billions of dollars to hire officers and immigration judges to speed up the process.CLICK HERE FOR MORE FOX NEWS OPINIONThats a key to addressing this backlog, not getting rid of due process. After all, due process isnt just for migrants its for you.Imagine, for a second, that youre stopped by an ICE officer under pressure to help this administration reach its goal of 1 million annual deportations. Do you carry something in your wallet that could prove youre a U.S. citizen? Do your kids? Do your parents?Certain non-citizens can obtain drivers licenses, so theyre not proof. Neither is a social security card.A passport works, but only about half of Americans have one. Do you know where your birth certificate is? Are you sure it isnt lost? Both items require time and paperwork to get not an option when youre about to be whisked out of the country.So, what will you tell ICE if they detain you? Even if you have proof, who will listen if you dont have a hearing?There is no such thing as "due process, but only for the good guys." Due process is how you the innocent prove your innocence. Without it, theres nothing stopping them from arresting Americans by accident and deporting them. If this administration gets rid of due process, anyone could be the next administrative error. Even you.

Texas mother Diana Atieh joins 'Fox & Friends' to discuss why she supports RFK Jr.'s agenda to make America healthier and the FDA's decision to review the nutrients included in infant formula for the first time in three decades.

Sen. Rand Paul, R-Ky., joins Fox & Friends to discuss HHS Secretary Robert F. Kennedy Jr.s defense of proposed cuts to his department during a hearing on Capitol Hill.

Karen Read is facing a retrial in the death of her Boston police officer boyfriend, John OKeefe.

'Fox & Friends' co-hosts react to a third book revealing details from the Biden administration and detailing what Democrats and the media knew about former President Biden's mental decline

Harrison Fields, special assistant to President Donald Trump, joins 'Fox & Friends' to discuss major economic agreements being made in the Middle East, the reported nuclear deal proposal for Iran and the state of U.S. relations with Syria

Final stop of Middle East tour expected to yield more business deals following $1.4 trillion investment pledge.

A loving big brother from Midlothian, Scotland, turned himself into a human stepping stool to help his little sister get onto a pony.